1986
DOI: 10.1097/00003246-198603000-00003
|View full text |Cite
|
Sign up to set email alerts
|

Bacteriuria in the catheterized surgical intensive care patient

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
13
0
1

Year Published

1992
1992
2016
2016

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 41 publications
(19 citation statements)
references
References 0 publications
1
13
0
1
Order By: Relevance
“…We observed an incidence density of ICU-acquired UTI of 9.6 per 1000 ICU days that is comparable to that observed in other studies that evaluated nosocomial UTIs in ICUs [2,9,10,17]. However, an important strength of this study is that all patients admitted to adult ICUs (both academic-based and community-based) in a large region were included.…”
Section: Discussionsupporting
confidence: 81%
“…We observed an incidence density of ICU-acquired UTI of 9.6 per 1000 ICU days that is comparable to that observed in other studies that evaluated nosocomial UTIs in ICUs [2,9,10,17]. However, an important strength of this study is that all patients admitted to adult ICUs (both academic-based and community-based) in a large region were included.…”
Section: Discussionsupporting
confidence: 81%
“…146,147 Infection Urinary infection can be a direct complication of persistent POUR (consequence of bladder hypotonia and the inability to completely empty the bladder) or an indirect complication of bladder catheterization. 148 Higher mortality rate has been reported in hospitalized patients who developed nosocomial urinary tract infection after indwelling bladder catheterization. 149 The incidence of bactremia after single catheterization has been reported to be as high as 8%.…”
Section: Autonomic Responsementioning
confidence: 99%
“…[94][95][96][97][98] These opioid-induced effects on the lower urinary tract can lead to secondary complications including bladder overdistension and reduced contractility, urinary tract infections, autonomic responses, such as hypertension, bradycardia, and cardiac dysrhythmias, increased hospital stay and costs, as well as increased morbidity in human patients. [99][100][101][102] Nonetheless, experimental and early clinical evidence suggests that opioids, such as tramadol which is a weak mu-receptor agonist, U-50488 which is a kappa-receptor agonist and morphine which is a pure mu-and kappa-receptor agonist, can mitigate detrusor overactivity and detrusor-sphincter dyssynergia and improve voiding efficiency. [81][82][83][84] Other potential therapeutic agents that target various sites within the peripheral and central micturition neuromodulatory pathways are mostly still at the experimental or early clinical stages of drug development.…”
Section: Medical Management Of Neurogenic Lower Urinary Tract Dysfuncmentioning
confidence: 99%